Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 556 AL 570

Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study

Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R.

Brain. 2010 Feb;133(Pt 2):540-56. doi: 10.1093/brain/awp280. Epub 2009 Nov 4.

Chapter 39: an historical overview of British neurology

Rose FC.

Handb Clin Neurol. 2010;95:613-28. doi: 10.1016/S0072-9752(08)02139-8.

The immunoregulatory role of dopamine: an update

Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S.

Brain Behav Immun. 2010 May;24(4):525-8. doi: 10.1016/j.bbi.2009.10.015. Epub 2009 Nov 5.

Levodopa inhibits the development of form-deprivation myopia in guinea pigs

Mao J, Liu S, Qin W, Li F, Wu X, Tan Q.

Optom Vis Sci. 2010 Jan;87(1):53-60. doi: 10.1097/OPX.0b013e3181c12b3d.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis

Walker AK, Farg MA, Bye CR, McLean CA, Horne MK, Atkin JD.

Brain. 2010 Jan;133(Pt 1):105-16. doi: 10.1093/brain/awp267. Epub 2009 Nov 10.

Autonomic assessment in Parkinson's disease: a measured stride forward

Cheshire WP.

Eur J Neurol. 2010 Feb;17(2):173-4. doi: 10.1111/j.1468-1331.2009.02833.x. Epub 2009 Nov 10.

Summary of GIGYF2 studies in Parkinson's disease: the burden of proof

Tan EK, Schapira AH.

Eur J Neurol. 2010 Feb;17(2):175-6. doi: 10.1111/j.1468-1331.2009.02834.x. Epub 2009 Nov 10.

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

Meltzer HY, Mills R, Revell S, Williams H, Johnson A, Bahr D, Friedman JH.

Neuropsychopharmacology. 2010 Mar;35(4):881-92. doi: 10.1038/npp.2009.176. Epub 2009 Nov 11.

Theory of mind in Parkinson's disease and related basal ganglia disorders: a systematic review

Bodden ME, Dodel R, Kalbe E.

Mov Disord. 2010 Jan 15;25(1):13-27. doi: 10.1002/mds.22818.

A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry

Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH.

Mov Disord. 2010 Jan 15;25(1):28-34. doi: 10.1002/mds.22858.

[Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease]

Goetz CG.

Rev Neurol (Paris). 2010 Jan;166(1):1-4. doi: 10.1016/j.neurol.2009.09.001. Epub 2009 Nov 12.

The role of AMP-activated protein kinase in the cardiovascular system

Nagata D, Hirata Y.

Hypertens Res. 2010 Jan;33(1):22-8. doi: 10.1038/hr.2009.187. Epub 2009 Nov 13.

Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis

Forjaz MJ, Ayala A, Rodriguez-Blazquez C, Frades-Payo B, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio longitudinal de pacientes con enferedad de Parkinson- ELEP Group.

Eur J Neurol. 2010 Feb;17(2):273-9. doi: 10.1111/j.1468-1331.2009.02835.x. Epub 2009 Nov 12.

Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review

Chambers JM, Prescott TJ.

Neuropsychologia. 2010 Mar;48(4):887-99. doi: 10.1016/j.neuropsychologia.2009.11.006. Epub 2009 Nov 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias